Drug name - Valchlor

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8501819 HELSINN Stabilized compositions of volatile alkylating agents and methods of using thereof Mar, 2026

(3 years from now)

US9382191 HELSINN Stabilized compositions of volatile alkylating agents and methods of using thereof Mar, 2026

(3 years from now)

US8450375 HELSINN Stabilized compositions of volatile alkylating agents and methods of using thereof Mar, 2026

(3 years from now)

US8501818 HELSINN Stabilized compositions of alkylating agents and methods of using same Mar, 2026

(3 years from now)

US7838564 HELSINN Stabilized compositions of volatile alkylating agents and methods of using thereof Mar, 2026

(3 years from now)

US7872050 HELSINN Stabilized compositions of volatile alkylating agents and methods of using thereof Jul, 2029

(6 years from now)

Drugs and Companies using MECHLORETHAMINE HYDROCHLORIDE ingredient

Treatment: Alkylating drug indicated for the topical treatment of stage ia and ib mycosis fungoides-type cutaneous t-cell lymphoma in patients who have received prior skin directed therapy

Dosage: GEL;TOPICAL

More Information on Dosage
Strength Dosage Availability
EQ 0.016% BASE GEL;TOPICAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.